191.021 articles found

LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.

Gómez-Suaga P, Rivero-Ríos P, Fdez E, Blanca Ramírez M, Ferrer I, Aiastui A, López De Munain A, Hilfiker S.

Hum Mol Genet · 2014-07-30

DOI: 10.1093/hmg/ddu395PMID: 25080504

Global attentional neglect of segmented lines in Parkinson's disease.

Falchook AD, Salazar L, Neal D, Kesayan T, Williamson JB, Malaty IA, McFarland NR, Okun MS, Rodriguez RL, Wagle Shukla A, Heilman KM.

Neurocase · 2014-07-30

DOI: 10.1080/13554794.2014.942671PMID: 25073971

Beta-band frequency peaks inside the subthalamic nucleus as a biomarker for motor improvement after deep brain stimulation in Parkinson's disease.

Michmizos KP, Frangou P, Stathis P, Sakas D, Nikita KS.

IEEE J Biomed Health Inform · 2014-07-30

DOI: 10.1109/jbhi.2014.2344102PMID: 25095273

Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson's disease.

Ellwanger JH, Molz P, Dallemole DR, Pereira dos Santos A, Müller TE, Cappelletti L, Gonçalves da Silva M, Franke SI, Prá D, Pêgas Henriques JA.

Nutrition · 2014-07-30

DOI: 10.1016/j.nut.2014.07.004PMID: 25592015

LFP and oscillations-what do they tell us?

Friston KJ, Bastos AM, Pinotsis D, Litvak V.

Curr Opin Neurobiol · 2014-07-30

DOI: 10.1016/j.conb.2014.05.004PMID: 25079053

NMDARs in neurological diseases: a potential therapeutic target.

Gonzalez J, Jurado-Coronel JC, Ávila MF, Sabogal A, Capani F, Barreto GE.

Int J Neurosci · 2014-07-30

DOI: 10.3109/00207454.2014.940941PMID: 25051426

Bir Ergen Olguda Sertralin Kullanımı ile İlişkili Servikal Distoni

Yazıcı, Kemal Utku, Perçinel, İpek

Fırat Tıp Dergisi, Vol. 19 No. 1 · 2014-07-29

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases.

Taymans JM, Baekelandt V, Harvey K.

Front Mol Neurosci · 2014-07-29

DOI: 10.3389/fnmol.2014.00071PMID: 25120428

Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment.

Ekman U, Eriksson J, Forsgren L, Domellöf ME, Elgh E, Lundquist A, Nyberg L.

Front Neurosci · 2014-07-29

DOI: 10.3389/fnins.2014.00207PMID: 25120418

Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.

Malec-Litwinowicz M, Rudzińska M, Szubiga M, Michalski M, Tomaszewski T, Szczudlik A.

Neurol Neurochir Pol · 2014-07-29

DOI: 10.1016/j.pjnns.2014.07.005PMID: 25168325

1,25-Dyhydroxyvitamin D₃ attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy.

Jang W, Kim HJ, Li H, Jo KD, Lee MK, Song SH, Yang HO.

Biochem Biophys Res Commun · 2014-07-29

DOI: 10.1016/j.bbrc.2014.07.081PMID: 25078626

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB.

Mov Disord · 2014-07-29

DOI: 10.1002/mds.25924PMID: 25073717